Pros and cons of new oral anticoagulants.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 464-470

  Bauer, Kenneth A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; THROMBIN; VITAMIN K GROUP;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; HEART ATRIUM FIBRILLATION; HUMAN; METHODOLOGY; ORAL DRUG ADMINISTRATION; PHYSIOLOGIC MONITORING; REVIEW; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; FACTOR XA; HUMANS; MONITORING, PHYSIOLOGIC; STROKE; THROMBIN; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 84898546596     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.464     Document Type: Review

References (0)